EUROPLUS™ ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis

Journal of Immunological Methods

Volumn 348, Issue 1-2, 2009, Pages 67-73

  Damoiseaux, Jan ^a   Steller, Ulf ^b   Buschtez, Michael ^b   Vaessen, Mia ^a   Rosemann, Anke ^b   van Paassen, Pieter ^a   Stöcker, Winfried ^b   Fechner, Kai ^b   Cohen Tervaert, Jan Willem ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute of Experimental Immunology   (Germany)

Author keywords

Anti neutrophil cytoplasmic antibodies; Autoantibodies; Vasculitis

Indexed keywords

ALCOHOL; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; AUTOANTIBODY; HYBRID PROTEIN; INTERLEUKIN 3; MYELOPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ARTICLE; BIOCHIP; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INCUBATION TIME; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ALGORITHM; ANALYTICAL EQUIPMENT; AUTOIMMUNE DISEASE; BLOOD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EVALUATION; IMMUNOASSAY; IMMUNOLOGY; PROTEIN MICROARRAY; WEGENER GRANULOMATOSIS;

ALGORITHMS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; IMMUNOASSAY; INTERLEUKIN-3; MYELOBLASTIN; PROTEIN ARRAY ANALYSIS; REAGENT KITS, DIAGNOSTIC; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; WEGENER GRANULOMATOSIS;

EID: 68549094196     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.07.001     Document Type: Article

References (31)

1. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988) 315
2. Birck R., Schmitt W.H., Kaelsch I.A., and Van der Woude F.J. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am. J. Kidney Dis. 47 (2006) 15
3. Bird A.G. Is there life in the formalin fixed neutrophil for ANCA testing? No!. J. Clin. Pathol. 52 (1999) 403
4. Boomsma M.M., Stegeman C.A., Oost-Kort W.W., Kallenberg C.G., Moguilevsky N., Limburg P.C., and Cohen Tervaert J.W. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis. J. Immunol. Methods 254 (2001) 47
5. Boomsma M.M., Damoiseaux J.G., Stegeman C.A., Kallenberg C.G., Patnaik M., Peter J.B., and Cohen Tervaert J.W. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J. Immunol. Methods 274 (2003) 27
6. Bosch X., Guilabert A., and Font J. Antineutrophil cytoplasmic antibodies. Lancet 368 (2006) 404
7. Choi H.K., Liu S., Merkel P.A., Colditz G.A., and Niles J.L. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J. Rheumatol. 28 (2001) 1584
8. Cohen Tervaert J.W., Huitema M.G., Hene R.J., Sluiter W.J., The T.H., van der Hem G.K., and Kallenberg C.G. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336 (1990) 709
9. Csernok E., Holle J., Hellmich B., Willem J., Tervaert C., Kallenberg C.G., Limburg P.C., Niles J., Pan G., Specks U., Westman K., Wieslander J., De Groot K., and Gross W.L. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 43 (2004) 174
10. Damoiseaux J.G., Slot M.C., Vaessen M., Stegeman C.A., Van Paassen P., and Cohen Tervaert J.W. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis. J. Clin. Immunol. 25 (2005) 202
11. Damoiseaux J., Dahnrich C., Rosemann A., Probst C., Komorowski L., Stegeman C.A., Egerer K., Hiepe F., Van Paassen P., Stocker W., Schlumberger W., and Cohen Tervaert J.W. A novel ELISA using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for ANCA-associated vasculitis. Ann. Rheum. Dis. 68 (2009) 228
12. Finkielman J.D., Merkel P.A., Schroeder D., Hoffman G.S., Spiera R., St Clair E.W., Davis Jr. J.C., McCune W.J., Lears A.K., Ytterberg S.R., Hummel A.M., Viss M.A., Peikert T., Stone J.H., and Specks U. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann. Intern. Med. 147 (2007) 611
13. Hagen E.C., Daha M.R., Hermans J., Andrassy K., Csernok E., Gaskin G., Lesavre P., Ludemann J., Rasmussen N., Sinico R.A., Wiik A., and Van der Woude F.J. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 53 (1998) 743
14. Han W.K., Choi H.K., Roth R.M., McCluskey R.T., and Niles J.L. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int. 63 (2003) 1079
15. Hellmich B., Csernok E., Fredenhagen G., and Gross W.L. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Clin. Exp. Rheumatol. 25 (2007) S1
16. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 1725
17. Jayne D.R., Gaskin G., Pusey C.D., and Lockwood C.M. ANCA and predicting relapse in systemic vasculitis. Qjm 88 (1995) 127
18. Jennette J.C., and Falk R.J. Small-vessel vasculitis. N. Engl. J. Med. 337 (1997) 1512
19. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37 (1994) 187
20. Kallenberg C.G., Mulder A.H., and Cohen Tervaert J.W. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am. J. Med. 93 (1992) 675
21. Lee S.S., Lawton J.W., and Chak W. Distinction between antinuclear antibody and P-ANCA. J. Clin. Pathol. 44 (1991) 962
22. Merkel P.A., Polisson R.P., Chang Y., Skates S.J., and Niles J.L. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann. Intern. Med. 126 (1997) 866
23. Rutgers A., Heeringa P., Damoiseaux J.G., and Cohen Tervaert J.W. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur. J. Intern. Med. 14 (2003) 287
24. Rutgers A., Damoiseaux J., Roozendaal C., Limburg P.C., Stegeman C.A., and Cohen Tervaert J.W. ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J. Clin. Immunol. 24 (2004) 435
25. Savige J., Gillis D., Benson E., Davies D., Esnault V., Falk R.J., Hagen E.C., Jayne D., Jennette J.C., Paspaliaris B., Pollock W., Pusey C., Savage C.O., Silvestrini R., van der Woude F., Wieslander J., and Wiik A. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am. J. Clin. Pathol. 111 (1999) 507
26. Savige J., Davies D., Falk R.J., Jennette J.C., and Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 57 (2000) 846
27. Savige J., Dimech W., Fritzler M., Goeken J., Hagen E.C., Jennette J.C., McEvoy R., Pusey C., Pollock W., Trevisin M., Wiik A., and Wong R. Addendum to the international consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am. J. Clin. Pathol. 120 (2003) 312
28. Van Paassen P., Van Breda Vriesman P.J., Van Rie H., and Cohen Tervaert J.W. Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry. Kidney Int. 66 (2004) 909
29. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., Pillemer S.R., Talal N., and Weisman M.H. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61 (2002) 554
30. Watts R., Lane S., Hanslik T., Hauser T., Hellmich B., Koldingsnes W., Mahr A., Segelmark M., Cohen Tervaert J.W., and Scott D. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann. Rheum. Dis. 66 (2007) 222
31. Westman K.W., Bygren P.G., Eilert I., Wiik A., and Wieslander J. Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol. Dial. Transplant. 12 (1997) 1863